Skip to content

The Use of Remimazolam Versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy

The Use of Remimazolam Versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07459322
Enrollment
60
Registered
2026-03-09
Start date
2026-08-05
Completion date
2027-12-31
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DISE, OSAS (Obstructive Sleep Apneas Syndrome), Sedation

Keywords

OSAS, DISE, Sedation, Remimazolam, Dexmedetomidine

Brief summary

This study seeks to compare the clinical efficacy and safety of the novel sedative Remimazolam with Dexmedetomidine in Drug-Induced Sleep Endoscopy (DISE), evaluating their performance in sedation depth stability, incidence of adverse events, and postoperative recovery time, thereby providing evidence-based guidance for sedative selection in OSA patients. Additionally, it aims to develop a model for predicting upper airway obstruction sites by analyzing Polysomnography (PSG) data with artificial intelligence, enhancing diagnostic accuracy and treatment decision-making efficiency for Obstructive Sleep Apnea (OSA) to optimize clinical management.

Interventions

DRUGRemimazolam

Patients with obsturctive sleep apne syndrome receiving remimazolam for sedation during drug-induced sleep endoscopy

DRUGDexmedetomidine

Patients with obsturctive sleep apne syndrome receiving dexmedetomidine for sedation during drug-induced sleep endoscopy

Sponsors

Fu Jen Catholic University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients age \> 18 years old * American Society of Ansthesiologists functional class \< III * Schedule to receive DISE exam for evaluation of OSAS

Exclusion criteria

* Patient refusal * Allergic to experimental medication * History of central nervous system diseases * History of psychiatric diseases * Pregnancy * Severe, uncontrolled systemic diseases

Design outcomes

Primary

MeasureTime frameDescription
Apneic eventsfrom start of sedation to outpatient discharge from postoperative care unitApnea event during sedation
Bradycardiafrom start of sedation to outpatient discharge from postoperative care unitHeart rate less than 60 beats per minute during sedation
Hypotensionfrom start of sedation to outpatient discharge from postoperative care unitHypotensive event (defined as less mean blood pressure less than 80% of preoperative mean blood pressure) during sedation
Agitationfrom start of sedation to outpatient discharge from postoperative care unitAgitation, coughing, involuntary movement during sedation
Surgeon satisfaction scoreFrom start of sedation to outpatient discharge from postoperative care unitRate of surgeon satisfaction of certain sedation
Hypoxic eventFrom start of sedation to outpatient discharge from postoperative care unithypoxic event during sedation

Secondary

MeasureTime frameDescription
Top-up requirementFrom start of sedation to outpatient discharge from postoperative care unitAdditional sedative agents given during sedation
Patient satisfaction scoreBefore outpatient discharge from postoperative care unitvalidated questionnaire regarding anesthesia quality in chinese after sedation for patients
VOTE classification predictionPerioperative phaseUsing electronic stethescope to collect snoring noise and predict VOTE classification

Countries

Taiwan

Contacts

CONTACTChao Hsien Sung, MD
joe411002@gmail.com0905302091

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026